Can macrocytic anemia with macrocytes, target cells, and tear-drop cells on peripheral blood smear be thalassemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Macrocytic Anemia with Macrocytes, Target Cells, and Tear-Drop Cells Be Thalassemia?

No, this presentation is highly unlikely to be thalassemia, as thalassemia characteristically causes microcytic anemia (MCV < 80 fL), not macrocytic anemia (MCV > 100 fL). 1

Why This Is Not Thalassemia

Thalassemia Produces Microcytic Anemia

  • Thalassemia is consistently classified as a cause of microcytic anemia with MCV < 80 fL 1
  • When thalassemia presents with elevated reticulocytes (hemoglobinopathies), it remains microcytic 1
  • The fundamental defect in hemoglobin synthesis in thalassemia results in small, hypochromic red blood cells, not large ones 1

Macrocytic Anemia Has Different Causes

The combination of macrocytic anemia (MCV > 100 fL) points toward entirely different etiologies 1:

With low/normal reticulocytes:

  • Vitamin B12 or folate deficiency (megaloblastic) 1, 2
  • Myelodysplastic syndrome (MDS) 1, 2
  • Medications (hydroxyurea, methotrexate, azathioprine, phenytoin) 1
  • Hypothyroidism 1
  • Alcoholism 1, 2
  • Liver disease 2

With elevated reticulocytes:

  • Hemolytic anemia (causes "false macrocytosis" from reticulocytosis) 1

The Peripheral Smear Findings Point Elsewhere

Target Cells and Tear-Drop Cells Are Non-Specific

  • While target cells can appear in thalassemia, they also occur in liver disease, hemoglobinopathies, and post-splenectomy states 3
  • Tear-drop cells (dacrocytes) are particularly concerning for myelofibrosis, MDS, or bone marrow infiltration 1
  • The combination of macrocytosis with tear-drop cells strongly suggests a primary bone marrow disorder like MDS rather than thalassemia 1

What You Should Look For Instead

Immediate next steps:

  • Examine the peripheral smear for macro-ovalocytes and hypersegmented neutrophils (≥5 lobes), which indicate megaloblastic anemia from B12/folate deficiency 2, 4
  • Check reticulocyte count to distinguish between decreased production versus hemolysis 1
  • Obtain vitamin B12 and folate levels 1, 2, 4
  • Review medication history for drugs causing macrocytosis 1

If megaloblastic features are absent:

  • Consider MDS, especially with tear-drop cells present 1
  • Evaluate thyroid function and liver enzymes 1, 2
  • Assess alcohol use history 1, 2

Critical Caveat: The Rare Exception

There is one extremely rare scenario where thalassemia trait could coexist with macrocytic anemia: when a thalassemic heterozygote develops superimposed folate or B12 deficiency 5. In this unusual situation:

  • The underlying microcytosis from thalassemia may be "masked" by the macrocytic process 5
  • The MCV might normalize or even become elevated 5
  • However, this would still not be "thalassemia causing macrocytic anemia"—it would be two separate conditions occurring simultaneously 5

Bottom line: If you see true macrocytic anemia with MCV > 100 fL, pursue the standard macrocytic anemia workup, not thalassemia evaluation. 1, 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of macrocytosis.

American family physician, 2009

Guideline

Peripheral Blood Smear Interpretation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of Macrocytic Anemias.

Seminars in hematology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.